Literature DB >> 23851429

Animal models and cell lines of pancreatic neuroendocrine tumors.

Varsha Babu1, Navin Paul, Run Yu.   

Abstract

Pancreatic neuroendocrine tumors (PNETs), also known as islet cell tumors, are mostly indolent neoplasms that probably arise from a network of endocrine cells that includes islet cells and pluripotent precursors in the pancreatic ductal epithelium. The incidence and prevalence of PNETs continue to rise in recent years because of more sensitive detection. The molecular pathogenesis, early detection, molecular predictors of tumor behavior, and targeted drug therapy of PNETs are not well understood and require additional basic and translational research. The rarity and indolent nature of these tumors, difficulty of access to appropriate patient tissue samples, and varying histopathology and secreted hormones pose particular challenges to PNET researchers. Animal models and cell lines are indispensable tools for investigating the pathogenesis, pathophysiology, mechanisms for tumor invasion and metastasis, and therapeutics of PNETs. This review summarizes currently available animal models and cell lines of PNETs, which have provided valuable insights into the pathogenesis and natural history of human PNETs. In the future, animal models and cell lines of PNETs should also be used to study early tumor detection and molecular predictors of tumor behavior and to test the responses to, and mechanisms for, novel targeted drug therapies.

Entities:  

Mesh:

Year:  2013        PMID: 23851429     DOI: 10.1097/MPA.0b013e31827ae993

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  9 in total

1.  Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors.

Authors:  Germano Gaudenzi; Manuela Albertelli; Alessandra Dicitore; Roberto Würth; Federico Gatto; Federica Barbieri; Franco Cotelli; Tullio Florio; Diego Ferone; Luca Persani; Giovanni Vitale
Journal:  Endocrine       Date:  2016-08-02       Impact factor: 3.633

2.  Establishment and Characterization of a Human Neuroendocrine Tumor Xenograft.

Authors:  Zhaoying Yang; Le Zhang; Stefano Serra; Calvin Law; Alice Wei; Tracy L Stockley; Shereen Ezzat; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

Review 3.  Elusive liver factor that causes pancreatic α cell hyperplasia: A review of literature.

Authors:  Run Yu; Yun Zheng; Matthew B Lucas; Yun-Guang Tong
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

4.  Parallel Signaling through IRE1α and PERK Regulates Pancreatic Neuroendocrine Tumor Growth and Survival.

Authors:  Paul C Moore; Jenny Y Qi; Maike Thamsen; Rajarshi Ghosh; Justin Peng; Micah J Gliedt; Rosa Meza-Acevedo; Rachel E Warren; Annie Hiniker; Grace E Kim; Dustin J Maly; Bradley J Backes; Feroz R Papa; Scott A Oakes
Journal:  Cancer Res       Date:  2019-10-31       Impact factor: 12.701

Review 5.  Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.

Authors:  E T Aristizabal Prada; C J Auernhammer
Journal:  Endocr Connect       Date:  2017-11-16       Impact factor: 3.335

6.  The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.

Authors:  Elke Tatjana Aristizabal Prada; Michael Orth; Svenja Nölting; Gerald Spöttl; Julian Maurer; Christoph Auernhammer
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

Review 7.  Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift.

Authors:  Helge L Waldum; Kjell Öberg; Øystein F Sørdal; Arne K Sandvik; Bjørn I Gustafsson; Patricia Mjønes; Reidar Fossmark
Journal:  Therap Adv Gastroenterol       Date:  2018-05-27       Impact factor: 4.409

Review 8.  Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations.

Authors:  Gabriel Benyomo Mpilla; Philip Agop Philip; Bassel El-Rayes; Asfar Sohail Azmi
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

9.  α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.

Authors:  Raj Kumar Verma; Wei Yu; Anju Shrivastava; Sharmila Shankar; Rakesh K Srivastava
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.